Related Experiment Video
Updated: Jun 6, 2026
08:09
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
The proteomic approach in Parkinson's disease
Mauro Fasano1, Bruno Bergamasco, Leonardo Lopiano
1Department of Structural and Functional Biology and Centre of Neuroscience, University of Insubria, Busto Arsizio (VA), Italy. mauro.fasano@uninsubria.it.
Proteomics. Clinical Applications
|December 8, 2010
Summary
Proteomics reveals a compromised antioxidant defense in Parkinson's disease (PD) pathogenesis. Further research using proteomic methods on cellular and animal models, alongside human tissue, is crucial for understanding PD molecular mechanisms.
Area of Science:
- Neuroscience
- Biochemistry
- Genetics
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder affecting 2% of individuals over 65.
- Its exact causes are unknown, but factors like mitochondrial dysfunction, oxidative stress, and inflammation are implicated.
- Limited access to human brain tissue hinders molecular studies, necessitating the use of models.
Purpose of the Study:
- To review the application of proteomic methodologies in Parkinson's disease research.
- To explore how proteomics investigates cellular and animal models of PD.
- To analyze proteomic comparisons between PD patient substantia nigra and control subjects.
Main Methods:
- Proteomic analysis of cellular and animal models of PD.
- Proteomic comparison of postmortem substantia nigra from PD patients and controls.
- Review of existing literature on proteomic studies in PD.
Main Results:
- Proteomic studies consistently indicate a weakened antioxidant defense system in PD.
- Proteomics has been applied to various PD models, including those focusing on protein aggregation and dopamine homeostasis.
- Comparative proteomic analysis highlights molecular differences in affected brain regions.
Conclusions:
- Proteomics offers valuable insights into the molecular underpinnings of Parkinson's disease.
- A compromised antioxidant defense is a key finding supported by proteomic evidence.
- The proteomic approach to PD research is emerging and holds promise for future discoveries.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:33Proteomics
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.